Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196) CORRESP

Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196) → SEC staff · filed 2026-04-01 · ticker CANF · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001213900-26-038553
Form
CORRESP
Filer
Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196)
CIK
0001536196
Ticker
CANF
Filed
2026-04-01
SIC industry
2834
HQ
Ramat Gan, L3

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1536196/000121390026038553/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗

Other comment-letter activity for this filer